The 36th Annual JP Morgan Healthcare Conference went down this week in our backyard of San Francisco. Otherwise known as JPM Week, it's an opportune time to get out and network amongst our peers in the Health Care industry.
On Tuesday we attended the Redox social mixer at Uno Dos Tacos in the SoMa district. While there, I got a chance to catchup with Stroll Health CEO Jordan Epstein.
Here's the transcript from our conversation:
Jordan Epstein: My biggest concern is that in the past couple of years, there's been this big move towards value-based care and then a lot of talk about trying to make a difference in terms of the actual outcomes for patients. Basically that hasn't actually translated into business. So a lot of these health systems, a lot of these investors, they're just not seeing the returns. They're not seeing the actual impact on the bottom line. My fear is there's gonna be a lot of still the talk, but then you know fewer and fewer of these new new players getting a chance in healthcare, really being able to make a difference. Honestly, you know with the move for the government and where the government is going, where the reimbursements are going, there's too much uncertainty. You know my fear is just not much is going to happen this year.
Hoala Greevy: Yeah. Thank you!
Stroll Health endeavors to create a world where healthcare is simple, transparent, and personalized for each person. Their technology gives doctors the information needed to send patients to best value care. Stroll improves access to care by showing options personalized for each patient and what’s covered, where the patient lives, how much they can pay, and more. Better value referrals help large fee-for-service systems improve revenue by bringing more patients back for care, value-based systems deliver more cost-effective treatment, and consumers get the right care at the right time at an affordable price.